BioMarin Pharmaceutical | 売上原価

株価
58.12
毎日の変更
0.97 1.70%
毎月
-5.20%
毎年
-9.09%
Q1 予測
54.80




売上原価 変化する 日付
Acadia Pharmaceuticals USD 21.65M 913K 2025-09
Agios Pharmaceuticals USD 1.68M 22K 2025-09
Alnylam Pharmaceuticals USD 200.15M 57.2M 2025-09
Amgen USD 1.79B 128M 2025-12
Bayer EUR 4.31B 57M 2025-09
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Gilead Sciences USD 1.57B 68M 2025-09
Incyte USD 99M 20.23M 2025-09
Insmed USD 30.9M 1.56M 2025-09
Ionis Pharmaceuticals USD 2.34M 1.81M 2025-09
Moderna USD 207M 88M 2025-09
Neurocrine Biosciences USD 264M 252.7M 2025-09
PTC Therapeutics USD 23.32M 7.83M 2025-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.76B 344M 2025-12
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Ultragenyx Pharmaceutical USD 27.99M 4.99M 2025-09
United Therapeutics USD 100.9M 74.3M 2025-09
Vertex Pharmaceuticals USD 414.8M 7.3M 2025-09


BioMarin Pharmaceutical 売上原価 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.